Silence Therapeutics plc (SLN)

Silence Therapeutics Statistics

Total Valuation

SLN has a market cap or net worth of $158.67 million. The enterprise value is $11.46 million.

Market Cap	158.67M
Enterprise Value	11.46M

Important Dates

The next estimated earnings date is Thursday, May 15, 2025, before market open.

Earnings Date	May 15, 2025
Ex-Dividend Date	n/a

Share Statistics

SLN has 47.22 million shares outstanding. The number of shares has increased by 24.69% in one year.

Current Share Class	n/a
Shares Outstanding	47.22M
Shares Change (YoY)	+24.69%
Shares Change (QoQ)	+0.34%
Owned by Insiders (%)	31.52%
Owned by Institutions (%)	37.65%
Float	21.60M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	3.59
Forward PS	n/a
PB Ratio	1.18
P/TBV Ratio	1.28
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	0.26
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 11.14, with a Debt / Equity ratio of 0.00.

Current Ratio	11.14
Quick Ratio	10.36
Debt / Equity	0.00
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -58.08% and return on invested capital (ROIC) is -39.61%.

Return on Equity (ROE)	-58.08%
Return on Assets (ROA)	-19.24%
Return on Invested Capital (ROIC)	-39.61%
Return on Capital Employed (ROCE)	-26.68%
Revenue Per Employee	$372,914
Profits Per Employee	-$390,595
Employee Count	116
Asset Turnover	0.27
Inventory Turnover	n/a

Taxes

In the past 12 months, SLN has paid $845,000 in taxes.

Income Tax	845,000
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -84.85% in the last 52 weeks. The beta is 1.25, so SLN's price volatility has been higher than the market average.

Beta (5Y)	1.25
52-Week Price Change	-84.85%
50-Day Moving Average	3.72
200-Day Moving Average	11.24
Relative Strength Index (RSI)	53.01
Average Volume (20 Days)	309,541

Short Selling Information

Short Interest	1.62M
Short Previous Month	1.47M
Short % of Shares Out	3.44%
Short % of Float	7.52%
Short Ratio (days to cover)	5.79

Income Statement

In the last 12 months, SLN had revenue of $43.26 million and -$45.31 million in losses. Loss per share was -$0.98.

Revenue	43.26M
Gross Profit	31.45M
Operating Income	-49.58M
Pretax Income	-52.45M
Net Income	-45.31M
EBITDA	-48.99M
EBIT	-49.58M
Loss Per Share	-$0.98

Balance Sheet

The company has $147.33 million in cash and $117,000 in debt, giving a net cash position of $147.22 million or $3.12 per share.

Cash & Cash Equivalents	147.33M
Total Debt	117,000
Net Cash	147.22M
Net Cash Per Share	$3.12
Equity (Book Value)	134.02M
Book Value Per Share	2.84
Working Capital	170.54M

Cash Flow

In the last 12 months, operating cash flow was -$67.64 million and capital expenditures -$211,000, giving a free cash flow of -$67.85 million.

Operating Cash Flow	-67.64M
Capital Expenditures	-211,000
Free Cash Flow	-67.85M
FCF Per Share	-$1.44

Margins

Gross margin is 72.70%, with operating and profit margins of -114.62% and -104.74%.

Gross Margin	72.70%
Operating Margin	-114.62%
Pretax Margin	-102.79%
Profit Margin	-104.74%
EBITDA Margin	-113.25%
EBIT Margin	-114.62%
FCF Margin	n/a

Dividends & Yields

SLN does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-24.69%
Shareholder Yield	n/a
Earnings Yield	-28.55%
FCF Yield	-42.76%

Analyst Forecast

The average price target for SLN is $40.80, which is 1,108.89% higher than the current price. The consensus rating is "Buy".

Price Target	$40.80
Price Target Difference	1,108.89%
Analyst Consensus	Buy
Analyst Count	5
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

SLN has an Altman Z-Score of 4.35 and a Piotroski F-Score of 3.

Altman Z-Score	4.35
Piotroski F-Score	3